[HTML][HTML] Brain tissue-derived extracellular vesicles in Alzheimer's disease display altered key protein levels including cell type-specific markers

…, DA Routenberg, R Nagaraj, J Redding… - Journal of …, 2022 - content.iospress.com
Background: Brain tissue-derived extracellular vesicles (bdEVs) play neurodegenerative
and protective roles, including in Alzheimer’s disease (AD). Extracellular vesicles (EVs) may …

[HTML][HTML] Bassoon contributes to tau-seed propagation and neurotoxicity

…, S Dutta, AB Wijeratne, J Redding-Ochoa… - Nature …, 2022 - nature.com
Tau aggregation is a defining histopathological feature of Alzheimer’s disease and other
tauopathies. However, the cellular mechanisms involved in tau propagation remain unclear. …

[HTML][HTML] Activated endothelial cells induce a distinct type of astrocytic reactivity

…, P Martinez, X Huang, Y You, J Redding-Ochoa… - Communications …, 2022 - nature.com
Reactive astrogliosis is a universal response of astrocytes to abnormal events and injuries.
Studies have shown that proinflammatory microglia can polarize astrocytes (designated A1 …

Enhanced mTORC1 signaling and protein synthesis in pathologic α-synuclein cellular and animal models of Parkinson's disease

…, HH Kim, H Gu, R Chen, J Redding-Ochoa… - Science translational …, 2023 - science.org
Pathologic α-synuclein plays an important role in the pathogenesis of α-synucleinopathies
such as Parkinson’s disease (PD). Disruption of proteostasis is thought to be central to …

Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer's disease neuropathologic changes and cognitive decline

K Chang, JP Ling, J Redding-Ochoa, Y An, L Li… - Acta …, 2024 - Springer
LATE-NC, the neuropathologic changes of limbic-predominant age-related TAR DNA-binding
protein 43 kDa (TDP-43) encephalopathy are frequently associated with Alzheimer’s …

[PDF][PDF] TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease

…, S Kim, W Yan, YS Li, SH Kuo, J Redding-Ochoa… - Neuron, 2021 - cell.com
Impairment in glucocerebrosidase (GCase) is strongly associated with the development of
Parkinson's disease (PD), yet the regulators responsible for its impairment remain elusive. In …

Deubiquitinase CYLD acts as a negative regulator of dopamine neuron survival in Parkinson's disease

…, MA Dar, E Lau, BG Kang, J Redding-Ochoa… - Science …, 2022 - science.org
Mutations in PINK1 and parkin highlight the mitochondrial axis of Parkinson’s disease (PD)
pathogenesis. PINK1/parkin regulation of the transcriptional repressor PARIS bears direct …

[HTML][HTML] MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study

…, L Molina-Porcel, T Gefen, J Redding-Ochoa… - The Lancet …, 2024 - thelancet.com
Background Pick's disease is a rare and predominantly sporadic form of frontotemporal
dementia that is classified as a primary tauopathy. Pick's disease is pathologically defined by the …

Hippocampal synaptic alterations associated with tau pathology in primary age-related tauopathy

M Morris, GI Coste, J Redding-Ochoa… - … of Neuropathology & …, 2023 - academic.oup.com
Primary age-related tauopathy (PART) is characterized by aggregation of tau in the mesial
temporal lobe in older individuals. High pathologic tau stage (Braak stage) or a high burden …

Mass spectrometry‐based proteomics analysis of human globus pallidus from progressive supranuclear palsy patients discovers multiple disease pathways

…, T Thuraisamy, J Redding‐Ochoa… - Clinical and …, 2022 - Wiley Online Library
Background Progressive supranuclear palsy (PSP) is a neurodegenerative disorder clinically
characterized by progressive postural instability, supranuclear gaze palsy, parkinsonism, …